Viewing Study NCT05525559


Ignite Creation Date: 2025-12-24 @ 2:52 PM
Ignite Modification Date: 2026-02-23 @ 8:31 PM
Study NCT ID: NCT05525559
Status: UNKNOWN
Last Update Posted: 2022-09-01
First Post: 2022-08-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: SHP2 Inhibitor ET0038 Monotherapy in Patients With Advanced Solid Tumors
Sponsor: Etern BioPharma (Shanghai) Co., Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module